We’re improving your experience!

Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.

Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.

Stay tuned for these updates, and thank you for being part of our community!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01610206
Title A Randomized Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian Cancer
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Linda R Duska
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Maine Medical Center (MMP Women's Health) Scarborough Maine 04074 United States Details
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore Maryland 21287 United States Details
Duke University Durham North Carolina 27710 United States Details
Stephenson Cancer Center University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 United States Details
MD Anderson Houston Texas 77030 United States Details
University of Virginia Charlottesville Virginia 22908 United States Details
Virginia Commonwealth University Richmond Virginia 23298 United States Details
University of Wisconsin-Madison Madison Wisconsin 53792 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field